Lanreotide Autogel® for Acromegaly: A New Addition to the Treatment Armamentarium

By Ciccarelli Antonio   Daly Adrian   Beckers Albert  

Treatments in Endocrinology, Vol. 3, Iss. 2, 2004-01 ,pp. : 77-81

Adis International

Access to resources Recommend Favorite

Rapid and sustained reduction of serum growth hormone and insulin-like growth factor-1 in patients with acromegaly receiving lanreotide Autogel^® therapy: a randomized, placebo-controlled, multicenter study with a 52 week open extension

By Melmed Shlomo   Cook David   Schopohl Jochen   Goth Miklos   Lam Karen   Marek Josef  

Pituitary, Vol. 13, Iss. 1, 2010-03 ,pp. : 18-28

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacologic Therapies for Acromegaly: A Review of Their Effects on Glucose Metabolism and Insulin Resistance

By Pereira Alberto M.   Biermasz Nienke R.   Roelfsema Ferdinand   Romijn Johannes A.  

Treatments in Endocrinology, Vol. 4, Iss. 1, 2005-01 ,pp. : 43-53

Adis International

Access to resources Recommend Favorite

A Systematic Review on Levosimendan in Paediatric Patients

By  

Current Vascular Pharmacology, Vol. 13, Iss. 1, 2015-01 ,pp. : 128-133

Bentham Science Publishers

Access to resources Recommend Favorite

Aliskiren in Patients with Diabetes: A Systematic Review

By  

Current Vascular Pharmacology, Vol. 10, Iss. 2, 2012-03 ,pp. : 140-146

Bentham Science Publishers

Access to resources Recommend Favorite